Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
TEVA Pharmaceutical Industries Limited Visits the NYSE - YouTube
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Gunjan Banerji on LinkedIn: On Page One of The Wall Street Journal today-my piece on the wild year it…
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Tries to Put an End to the Opioid Wars - WSJ
WSJ markets desk names new night editor - Talking Biz News
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Faces U.S. Criminal Probe on Opioid-Related Distribution, Report Says | Ctech
Mylan sees opportunity in rival Teva's weakness - MarketWatch
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Pfizer, Takeda Reach $2.15 Billion Settlement With Teva, Sun Pharma - WSJ
Teva Settles Foreign Corruption Probe for $519 Million - WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ
